These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6624772)

  • 1. Computed tomographic scanning versus radioisotope imaging in adrenocortical diagnosis.
    Guerin CK; Wahner HW; Gorman CA; Carpenter PC; Sheedy PF
    Am J Med; 1983 Oct; 75(4):653-7. PubMed ID: 6624772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical scintigraphy.
    Troncone L; Danza FM
    Rays; 1992; 17(1):34-9. PubMed ID: 1636016
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
    Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
    Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
    Barliev GB
    Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of adrenal venography and iodocholesterol scan in adrenal surgery.
    Herwig KR; Sonda LP
    J Urol; 1979 Jul; 122(1):7-8. PubMed ID: 458994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasms including incidentalomas.
    Thompson NW; Cheung PS
    Surg Clin North Am; 1987 Apr; 67(2):423-36. PubMed ID: 3551152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiocholesterol scintigraphy in Cushing's syndrome.
    Rufini V; Saletnich I; Troncone L
    Rays; 1992; 17(1):40-8. PubMed ID: 1636017
    [No Abstract]   [Full Text] [Related]  

  • 8. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
    Kao CH; Liao SQ; Wang SJ; Lin MS; Hsu CY; Lin WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Apr; 8(4):213-8. PubMed ID: 1578517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma.
    Ruíz Hernández G; Pallarés FJ; Bartual AR; Tenes Rodrigo S; Ampudia-Blasco FJ; de Avila y Avalos CR
    Nuklearmedizin; 1998 Jun; 37(4):141-5. PubMed ID: 9650214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintigraphy with 131I-19-iodocholesterol in adrenal disease.
    Jorgensen H; Norman N; Sundsfjord JA
    Acta Med Scand; 1975 May; 197(5):345-51. PubMed ID: 1146612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I-19-iodocholesterol scintigraphy of the adrenal cortex.
    Dige-Petersen H; Munkner T; Fogh J; Blichert-Toft M; Lund JO
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):81-94. PubMed ID: 1173986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
    Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
    Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
    Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
    J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic imaging of endocrine diseases. Adrenal cortex neoplasms].
    Hanew K; Yoshinaga K
    Nihon Rinsho; 1987 Nov; 45(11):2493-500. PubMed ID: 3444045
    [No Abstract]   [Full Text] [Related]  

  • 15. Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
    Yu KC; Fraker DL; Ziessman HA
    Clin Nucl Med; 1996 Feb; 21(2):136-41. PubMed ID: 8697685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing benign from malignant euadrenal masses.
    Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
    Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
    Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
    Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
    [No Abstract]   [Full Text] [Related]  

  • 19. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
    La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
    J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
    Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.